Want to see CH:TECN full AI Analyst Report?
TECN Stock Chart & Stats
CHF182.20
-CHF3.00(-1.65%)
At close: 4:00 PM EDT
CHF182.20
-CHF3.00(-1.65%)
Day’s Range― - ―
52-Week RangeCHF110.60 - CHF202.00
Previous CloseN/A
Volume20.71K
Average Volume (3M)44.12K
Market Cap
CHF2.50B
Enterprise ValueCHF2.00K
Total Cash (Recent Filing)CHF224.63M
Total Debt (Recent Filing)CHF214.32M
Price to Earnings (P/E)―
Beta1.31
Next Earnings
Mar 16, 2027EPS Estimate
3.91Next Dividend Ex-DateN/A
Dividend Yield1.53%
Share Statistics
EPS (TTM)-9.16
Shares Outstanding12,825,883
10 Day Avg. Volume56,389
30 Day Avg. Volume44,118
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)1.41
Price to Sales (P/S)1.84
P/FCF Ratio15.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF194.50Price Target Upside6.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)6.21
Revenue Forecast (FY)CHF884.53M
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Low LeverageTecan's low debt-to-equity through 2021–2025 provides durable financial flexibility to fund multi-year programs, absorb operating volatility, support working-capital needs, and preserve investment-grade-like optionality. This conservatism reduces refinancing and covenant risk while enabling strategic moves.
Consistent Positive Operating & Free Cash FlowSustained positive operating and free cash flow, even amid weaker reported earnings, indicates the business converts sales into cash reliably. That cash shield supports ongoing service/consumable operations, funds transformation spend and shareholder returns, and cushions execution risks over the next 2–6 months and beyond.
Clear Multi-year Rewired Program And Strategic InitiativesManagement has a defined, resourced transformation (Rewired) with quantified 2028 targets plus early, measurable savings and strategic partnerships (e.g., NVIDIA). This structural plan, if executed, can sustainably lift top-line growth and margins via productivity, product mix, and digital/AI-enabled capabilities over multiple years.
Bears Say
Multi‑year Revenue Decline And Recent Net LossA multi-year top-line decline and a 2025 net loss materially weaken the installed base and recurring consumables/services tail. Prolonged revenue erosion reduces scale, harms long-term margin recovery, and makes hitting the company’s multi-year growth and EBITDA targets materially harder without clear and sustained demand recovery.
Gross Margin Compression From Structural Cost PressuresA ~230bp gross margin squeeze driven by inflation, inventory effects, FX and tariffs signals persistent cost headwinds. Unless permanently offset by pricing, mix shift to higher-margin products, or productivity gains from Rewired, these structural margin pressures will constrain sustainable cash generation and EBITDA improvement.
Operating Cash Flow Weakness And Shrinking LiquidityA meaningful drop in operating cash flow, higher receivables and inventory, and lower net liquidity reduce the company’s buffer for transformation investments and supply-chain recovery. Combined with non-recurring Rewired/Elevate costs and prior shareholder payouts, this constrains optionality and raises execution risk on multi-year targets.
Tecan Group AG News
TECN FAQ
What was Tecan Group AG’s price range in the past 12 months?
Tecan Group AG lowest stock price was CHF110.60 and its highest was CHF202.00 in the past 12 months.
What is Tecan Group AG’s market cap?
Tecan Group AG’s market cap is CHF2.50B.
When is Tecan Group AG’s upcoming earnings report date?
Tecan Group AG’s upcoming earnings report date is Mar 16, 2027 which is in 213 days.
How were Tecan Group AG’s earnings last quarter?
Tecan Group AG released its earnings results on Aug 11, 2026. The company reported CHF2.62 earnings per share for the quarter, beating the consensus estimate of CHF2.51 by CHF0.11.
Is Tecan Group AG overvalued?
According to Wall Street analysts Tecan Group AG’s price is currently Undervalued.
Does Tecan Group AG pay dividends?
Tecan Group AG pays a Annually dividend of CHF3 which represents an annual dividend yield of 1.53%. See more information on Tecan Group AG dividends here
What is Tecan Group AG’s EPS estimate?
Tecan Group AG’s EPS estimate is 3.91.
How many shares outstanding does Tecan Group AG have?
Tecan Group AG has 12,825,883 shares outstanding.
What happened to Tecan Group AG’s price movement after its last earnings report?
Tecan Group AG reported an EPS of CHF2.62 in its last earnings report, beating expectations of CHF2.51. Following the earnings report the stock price went down -10.297%.
Which hedge fund is a major shareholder of Tecan Group AG?
Currently, no hedge funds are holding shares in CH:TECN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tecan Group AG
Tecan Group AG, established in 1980 and headquartered in Männedorf, Switzerland, specializes in providing cutting-edge laboratory instruments and holistic solutions. The company caters to a broad spectrum of clients, including pharmaceutical and biotechnology corporations, university research departments, and forensic and diagnostic laboratories. Its operations are structured into two principal segments: Life Sciences Business and Partnering Business. Tecan's extensive product portfolio features automated liquid handling systems, microplate readers and washers, various consumables, reagents for Next-Generation Sequencing (NGS), immunoassays, microbodies, and specialized software. Key proprietary solutions include Tecan Laberwax for automated workflows and Resolvex, an intelligent sample preparation system applicable across diverse fields such as genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, applied markets, and ELISA. Additionally, Tecan develops and manufactures crucial components—like precision pumps, valves, robotic arms, and developer software—for other laboratory instrument producers serving life science research, diagnostics, and various industrial applications. Its advanced platform-based automation solutions include Synergence, Freedom EVO, and Fluent instruments. The company's global footprint spans Switzerland, other European nations, North America, Asia, and other international markets.
TECN Company Deck
TECN Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call painted an overall constructive picture: Tecan delivered above-market sales growth in local currencies, maintained a healthy book-to-bill and recorded a resilient adjusted EBITDA margin with underlying profitability improvement. Management confirmed multi-year targets and reported early, tangible benefits from the Rewired transformation alongside strategic AI and geographic initiatives. However, material challenges remain — gross margin compression (material inflation, FX and tariffs), weaker operating cash flow, supply-chain shipment delays (Cavro), upfront transformation and IT costs, and weakness in the Academia & Government end market. On balance, the positive operational momentum, validated guidance and strategic progress outweigh the near-term financial and operational headwinds, but the company must execute Rewired and Elevate while stabilizing cash conversion and margins.View all CH:TECN earnings summariesTECN Stock 12 Month Forecast
Average Price Target
CHF194.50
▲(6.75% Upside)
Technical Analysis
Medacta Group SA
―
Siegfried Holding AG
―
Ypsomed Holding AG
―
SKAN Group AG
―
Medartis Holding AG
―